-
redOrbit - Wed Nov 25, 11:24 am ET
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
-
PR Newswire via Yahoo! Finance - Wed Nov 25, 7:32 am ET
Reportlinker.com announces that a new market research report is available in its catalogue:
-
Nasdaq - Tue Nov 24, 4:02 pm ET
HOLLY SPRINGS, N.C. -(Dow Jones)- Swiss drug maker Novartis AG (NVS, NOVN.VX) opened a vaccine-manufacturing plant Tuesday designed to make influenza vaccines without relying on decades-old technology that employs millions of chicken eggs to grow viruses.
-
Center for Infectious Disease Research and Policy - Tue Nov 24, 8:34 pm ET
Nov 24, 2009 (CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.
-
PharmaceuticalOnline - Tue Nov 24, 9:02 am ET
GlaxoSmithKline (GSK) today announced that over 40 million doses of its adjuvanted pandemic H1N1 vaccine have been distributed to countries globally for use in government-initiated vaccination programmes.
-
Standard-Examiner - Tue Nov 24, 11:29 am ET
Cover your sneezes. Stay home if you are sick. Wash those hands. -- read more
-
Tulsa World - Tue Nov 24, 3:39 am ET
Swine flu circulation in Oklahoma may have hit its peak — at least for now, health officials say.
-
San Bernardino Sun - Tue Nov 24, 2:11 am ET
LOMA LINDA - If there's a lesson to be learned from the H1N1 influenza virus, it is that the nation's vaccine production must be modernized, a top public-health official said here Monday.
-
PR Newswire via Yahoo! Finance - Tue Nov 24, 8:00 am ET
Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 8 a.m.
-
Science Daily - Mon Nov 16, 9:18 pm ET
New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say. The researchers linked many powerful computer systems together to analyze enormous amounts of genetic data collected from all publicly available isolated strains of the H5N1 ...
-
GlobeNewswire via Yahoo! Finance - Mon Nov 23, 10:47 am ET
WORCESTER, Mass. -- Generex Biotechnology Corporation announced today that Dr. Douglas Powell, Director of Immunobiology at Antigen Express, Inc. , Generex's wholly-owned immunotherapeutics subsidiary, made a presentation on the Company's H1N1 Swine Flu program at a national symposium on influenza.
-
Business Wire via Yahoo! Finance - Mon Nov 23, 7:00 am ET
WEST HAVEN, Conn.----NanoViricides, Inc. , announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC .
-
Center for Infectious Disease Research and Policy - Mon Nov 16, 6:19 pm ET
FDA backs off on Gulf Coast oyster safety plan In response to protests from the oyster industry and politicians, the Food and Drug Administration (FDA) recently announced the suspension, pending further study, of a plan to prevent the summertime contamination of Gulf Coast oysters by Vibrio vulnificus bacteria.
-
Business Wire via Yahoo! Finance - Fri Nov 20, 6:00 am ET
SAN DIEGO----Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.
-
Fox News - Fri Nov 20, 6:15 pm ET
Vaccine-maker Novavax said Friday it plans to sell 6.8 million shares of its stock.